Press What’s news at AbelsonTaylor Group
Select category
Moving Into 2024
Applying his background in pharmacology, Jeff Berg, President of AbelsonTaylor Group, discusses a particularly exciting use of AI in drug discovery that is tackling one of biology’s biggest challenges – predicting the 3D shape of proteins and designing them from scratch. Read more at https://www.pharmalive.com/healthcare-agency-roundtable-2024-moving-into-2025/
Media Contact:
Recent Posts
As Bluesky continues to grow, opportunities abound for pharma brands
With over 30 million users, Bluesky Social is quickly gaining steam. Associate Director of Engagement Helen Hoye recently spoke to...
In the News Read more As Bluesky continues to grow, opportunities abound for pharma brandsBridging the gap in pharma marketing: Connecting pharma, HCPs, and patients for better communication
In MedAdNew’s bulletin, PharmaLive, Lynnette Hunter, EVP-Director of Client Services, offers a five-step approach to connecting pharma, HCPs and patients...
In the News Read more Bridging the gap in pharma marketing: Connecting pharma, HCPs, and patients for better communicationPrioritizing Mental Health
Prioritizing mental well-being can transform lives and careers. Read VP, Account Director Jeremy Vannatta’s story in the March 2025 mental...
In the News Read more Prioritizing Mental HealthConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.